Sarmey Nehaw, Kaisman-Elbaz Tehila, Mohammadi Alireza M
Department of Neurosurgery, Rose Ella Burkhardt Brain Tumor and Neuro-oncology Center, Cleveland Clinic, Cleveland, OH, United States.
Front Oncol. 2022 Feb 18;12:827304. doi: 10.3389/fonc.2022.827304. eCollection 2022.
Brain metastases represent the most common intracranial neoplasm and pose a significant disease burden on the individual and the healthcare system. Although whole brain radiation therapy was historically a first line approach, subsequent research and technological advancements have resulted in a larger armamentarium of strategies for treatment of these patients. While chemotherapeutic options remain limited, surgical resection and stereotactic radiosurgery, as well as their combination therapies, have shifted the paradigms for managing intracranial metastatic disease. Ultimately, no single treatment is shown to be consistently effective across patient groups in terms of overall survival, local and distant control, neurocognitive function, and performance status. However, close consideration of patient and tumor characteristics may help delineate more favorable treatment strategies for individual patients. Here the authors present a review of the recent literature surrounding surgery, whole brain radiation therapy, stereotactic radiosurgery, and combination approaches.
脑转移瘤是最常见的颅内肿瘤,给患者个人和医疗系统带来了沉重的疾病负担。虽然全脑放射治疗在历史上是一线治疗方法,但随后的研究和技术进步带来了更多治疗这些患者的策略。虽然化疗选择仍然有限,但手术切除、立体定向放射外科及其联合治疗已经改变了颅内转移性疾病的管理模式。最终,就总生存期、局部和远处控制、神经认知功能及功能状态而言,没有一种单一治疗方法在所有患者群体中都被证明始终有效。然而,仔细考虑患者和肿瘤特征可能有助于为个体患者制定更有利的治疗策略。在此,作者对围绕手术、全脑放射治疗、立体定向放射外科及联合治疗方法的近期文献进行综述。